HealthDay News, Aug. 21, 2023 -- A study published online Aug.

[{"selector":"#anim-73603316-5f6c-4750-b4fa-07f67fa7ef6d [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-21.874999829338588%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":9000,"fill":"forwards"}] more than placebo for two years in patients with immunoglobulin A (IgA) nephropathy.

[{"selector":"#anim-d2a47a5a-300d-4cca-bfd0-285d344beb1e [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-35.37499991125607%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":9000,"fill":"forwards"}] targeted-release budesonide (Nefecon) treatment reduces estimated glomerular filtration rate

[{"selector":"#anim-689cdf5a-6e9d-4fb3-a17f-40d139d4df0f [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-30.136718629470376%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":9000,"fill":"forwards"}] . 14 in The Lancet found that nine months of targeted-release budesonide

[{"selector":"#anim-7c52e9e4-8b59-481f-8b7d-b9f07e8d3a26 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-31.22656238608351%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":9000,"fill":"forwards"}] Richard Lafayette, M.D., from Stanford University in California

[{"selector":"#anim-7c9331bc-c9b8-4804-9ff5-f11ba26cfd4b [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-12.514648210040342%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":9000,"fill":"forwards"}] randomized study in persons with primary IgA nephropathy

[{"selector":"#anim-5e5f036a-3cc7-4a47-9023-be189a69763e [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-34.179687404002955%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":9000,"fill":"forwards"}] for nine months followed by a 15-month observational follow-up.

[{"selector":"#anim-c29ebf30-1ecd-45cf-8248-e226040e98b0 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-21.874999829338588%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":9000,"fill":"forwards"}] The study found that budesonide significantly improved eGFR over two years compared to placebo

[{"selector":"#anim-4290c1e8-8c05-4147-ae1c-c3a8111b3dc6 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-12.514648210040342%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":9000,"fill":"forwards"}] There were no treatment-related fatalities.

Gauff wins the Cincinnati Open by defeating Muchova.

[{"selector":"#anim-b99078b8-c4a5-4cc3-a342-d4f595b286d9","keyframes":{"opacity":[0,1]},"delay":200,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-3e7485b1-dc9c-4af8-a572-cc21242a8e23 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(-3.552713678800501e-15%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] swip up